SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology shares faced a significant sell-off following fiscal Q1 results, as investors reacted to concerns regarding margin compression and customer concentration, despite the company exceeding revenue and earnings estimates. While some traders view the price drop as a value-buying opportunity given the company's strong AI-driven growth trajectory, others remain cautious of ongoing market volatility and broader macroeconomic headwinds.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

The primary catalyst for the stock's recent price drop is a ruling by the Federal Circuit affirming the invalidation of several older patents. Traders are debating whether this is a significant negative or a 'nothingburger,' as the community largely emphasizes that these specific patents are not linked to the substantial ongoing litigation and $445 million judgment against Micron, which remains the central focus for investors.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending after delivering record quarterly results that significantly topped Wall Street estimates, driven by surging AI server demand and a massive increase in its full-year revenue outlook. While some traders are celebrating the blowout figures and subsequent price target hikes from analysts, others are expressing frustration over the stock's volatile price action and broader market headwinds.

FuelCell Energy, Inc. is an American clean energy technology company that delivers continuous, scalable baseload power for mission-critical applications globally. It engages in the development, design, production, construction, operation, and servicing of high-temperature fuel cells for clean electric power generation. The company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emission power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems backed by global fuel cell deployments approaching one gigawatt. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing high volatility as traders debate the potential for the company to capitalize on the AI data center buildout and the upcoming September earnings release, following a recent decline in stock price. While some traders view the pullback as a buying opportunity based on the company's 10-gigawatt pipeline and manufacturing expansion, others remain skeptical due to historical earnings misses and concerns over persistent share dilution.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is seeing increased volatility and high message volume following a quarterly earnings report that beat analyst expectations. While the company issued an upbeat fiscal 2027 outlook and announced the acquisition of Console, traders are debating the company's valuation and the impact of its M&A strategy on organic growth.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is experiencing high volatility as investors debate its valuation amid broader software sector weakness. While some traders are taking profits and shorting the stock citing a high P/E ratio, others view the pullback as a buying opportunity based on the company's contract momentum and enterprise growth.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

LightPath Technologies is trending following a significant price decline, with the community attributing the weakness to broader small-cap sector volatility and uncertainty regarding the timeline of the Next Generation Short Range Interceptor (NGSRI) program. While some traders express frustration with the lack of recent company-specific announcements, many remain bullish, viewing the current price levels as a buying opportunity based on the company's backlog, BlackDiamond material adoption, and long-term positioning in the defense and drone sectors.

Magnite, Inc. provides a technology solution to automate the purchase and sale of digital advertising inventory for buyers and sellers. It features applications and services for digital advertising sellers including websites, mobile applications, and other digital media properties. The company was founded by Frank Addante, Duc Chau, Craig Roah, Julie Mattern and Brian D. Baumgart on April 20, 2007 and is headquartered in New York, NY.

Magnite Inc

Magnite is trending as investors react to strong quarterly earnings featuring double-digit growth in Connected TV revenue and raised full-year guidance. Traders are also closely monitoring the long-awaited Google ad-tech antitrust ruling, with many viewing Magnite as well-positioned to gain market share if behavioral remedies are implemented.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Federal cannabis rescheduling is the dominant catalyst, with traders focused on DEA/DOJ support for moving marijuana to Schedule III and awaiting the administrative law judges recommendation. The community is broadly bullish on potential 280E tax relief and institutional access, while others caution that the recommendation is not final and debate whether the news is already priced in amid repeated resistance near a key options level.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB shares dropped significantly after the company's fiscal Q3 revenue guidance disappointed investors, despite reporting a beat-and-raise quarter. The community is debating whether the deceleration in Atlas cloud revenue growth signals a long-term peak or a temporary period of moderation, with many traders speculating on potential entry points while others express frustration over the company's valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Bixlenvo Unlock New Growth for Gilead's HIV Business?

GILD's FDA approval of Bixlenvo expands its HIV portfolio with a first-of-its-kind single-tablet option for underserved patients.

GSK Stock Down 14% in Six Months: Time to Buy, Hold or Exit?

GSK's shares are down 14% in six months, but strong Specialty Medicines growth and a robust pipeline may support long-term gains.

EC Approves Label Expansion of GILD's Trodelvy in First-line Metastatic TNBC

Trodelvy's latest EU approval with Keytruda expands its first-line metastatic TNBC use, strengthening Gilead???s oncology growth opportunity.

GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer

GSK's Jemperli gets FDA priority review for dMMR/MSI-H rectal cancer with a decision due in February 2027, while Hibsago wins Japan approval in CHB.

GSK Makes Bullish Cross Above Critical Moving Average

In trading on Wednesday, shares of Gsk plc American Depositary Shares (each Represent (Symbol: GSK) crossed above their 200 day moving average of $52.03, changing hands as high as $52.73 per share. Gsk plc American Depositary Shares (each Represent shares are currently trading...

Vaccine-Maker Claims Splitting MMR Shot Could Take Up To 10 Years

Vaccine-Maker Claims Splitting MMR Shot Could Take Up To 10 Years

 Authored by Zachary Stieber via The Epoch Times,

Splitting the measles, mumps, rubella (MMR) vaccine into separate shots could take up to a decade, according to one of the two companies that produce the vaccine for the...

Is Gilead's Expanding HIV Portfolio a Growth Catalyst?

Gilead's HIV franchise gains momentum as Yeztugo ramps up, Biktarvy leads treatment and new pipeline advances strengthen growth prospects.

PFE, MRK, SNY, MRNA In Focus As Trump Reportedly Eyes Executive Order On Vaccines And Autism

Equity

The order’s contents remain unclear, and timing could shift, Bloomberg reported, citing people familiar with the matter.


Moderna's mRNA Flu Vaccine Approved By FDA

Moderna's mRNA Flu Vaccine Approved By FDA

 Authored by Rachel Roberts via The Epoch Times,

The U.S. Food and Drug Administration has approved Moderna's flu shot for over-50s, marking the first time the agency has licensed a messenger ribonucleic acid (mRNA) vaccine for seasonal...

GILD Q2 Earnings Beat on HIV and Trodelvy Growth, Product Sales Outlook Raised

GILD beats Q2 revenue estimates as HIV sales fuel growth, while acquisition charges cause a loss. Higher HIV guidance and pipeline progress support momentum.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations and Total Research and Development. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in London, the United Kingdom.

Feed

News

Sentiment

Earnings

Fundamentals

Info

GSK Glaxosmithkline plc - ADR

Fundamentals

Latest GSK News